Hemispherx BioPharma, Inc(AMEX: HEB) stock decreased 31.74% to $0.440. The companys rintatolimod (trade name Ampligen) will be reviewed by an FDA Advisory Committee on December 20, 2012 for the treatment of chronic fatigue syndrome (CFS). Because the etiology of CFS is unknown, such a review presents unusual regulatory and scientific challenges, though of course drugs are approved for conditions whose pathophysiology is incompletely understood, such as the common headache.
Will HEB Move Higher After Todays Sudden Selling Activities? Dont Miss The Free Trend Analysis here http://csrnewsdaily.com/c1/?company=HEB
YM BioSciences Inc. (USA)(AMEX: YMI) shares is trading at $2.87 in the early hour. Gilead Sciences Inc and YM BioSciences Inc announced that the companies have signed a definitive agreement under which Gilead will acquire YM for USD2.95 per share in cash. The transaction has received the unanimous approval of YM`s Board of Directors, and values YM at approximately USD10 million, with YM reporting CAD125.5 million in cash and cash equivalents as of September 30, 2012. Gilead plans to fund the acquisition with cash on hand. The transaction is expected to close in the first quarter of 2013.
How Should Investors Trade YMI After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c1/?company=YMI
Cheniere Energy, Inc.(AMEX: LNG) shares gained 1.92% to $18.09 after equities researchers at Credit Suisse increased their target price on shares of Cheniere Energy from $22.00 to $25.00 in a report issued today. The firm currently has an outperform rating on the stock.
The company last posted its quarterly earnings results on Monday, November 5th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.29. The company had revenue of $66.30 million for the quarter, compared to the consensus estimate of $68.90 million.
Get Free Special Trend Analysis On LNG Here http://csrnewsdaily.com/c1/?company=LNG
Rubicon Minerals Corp. (USA)(AMEX: RBY) stock fell 8.96% to $2.44. The company has learned via press reports that, on December 17, 2012, Wabauskang First Nation ("WFN") instructed its lawyers to file a lawsuit related to Rubicon's Phoenix Gold Project in Red Lake, Ontario. At this time, since it has received no notice from WFN, the details of its lawsuit are unknown to Rubicon.
Get Free Special Trend Analysis On RBY Here http://csrnewsdaily.com/c1/?company=RBY
Rentech, Inc.(AMEX: RTK) shares increased 1.38% to $2.57. The company has announced an ex-dividend date of December 18, 2012 and a cash dividend payment of $0.19 per share scheduled for December 27, 2012. Shareholders who purchased RTK stock prior to the ex-dividend date are eligible for the cash dividend payment.
Get Free Special Trend Analysis On RTK Here http://csrnewsdaily.com/c1/?company=RTK
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062